Zhejiang Huahai Pharmaceutical Co., Ltd. Class A · SSE:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. Class A shareholders

Zhejiang Huahai Pharmaceutical Co., Ltd. Class A on 6ix: holders from US fund reports. Largest: Vanguard Total International Stock Index Fund, Vanguard Emerging Markets Stock Index Fund and Emerging Markets Core Equity 2 Portfolio. Each with its filing.

HolderShares% of Zhejiang Huahai Pharmaceutical Co., Ltd. Class AChangeAs of
Vanguard Total International Stock Index Fund1.46Mno changeJul 31, 2026
Vanguard Emerging Markets Stock Index Fund1.41Mno changeJul 31, 2026
Emerging Markets Core Equity 2 Portfolio297K−156KJul 31, 2026
WisdomTree Emerging Markets SmallCap Dividend Fund277K−3,000Jun 30, 2026
Vanguard Ftse All-World Ex-Us Index Fund266K+47,000Jul 31, 2026
Dimensional Emerging Markets Value Fund248KnewJul 31, 2026
Schwab Emerging Markets Equity ETF140Kno changeMay 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF104K+9,200Jul 31, 2026
Dimensional Emerging Core Equity Market ETF90,500−9,000Jul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF79,610no changeJul 31, 2026

Zhejiang Huahai Pharmaceutical Co., Ltd. Class A insider trades